Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2008

01-02-2008 | Case Report

Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report

Authors: Paola Caramaschi, Alessandro Volpe, Antonio Carletto, Lisa Maria Bambara, Domenico Biasi

Published in: Rheumatology International | Issue 4/2008

Login to get access

Abstract

The authors describe a young man suffering from systemic sclerosis who showed a dramatic progression of skin involvement after the appearance of anti-Scl70 antibody.
Literature
1.
Derk CT, Jimenez SA (2003) Systemic sclerosis: current view of its pathogenesis. Autoimmun Rev 2:181–191PubMedCrossRef
2.
Walker UA, Tyndall A, Czirjak L, Denton C., Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M and EUSTAR Co-authors (2007) Clinical risk assessment of organ manifestations in systemic sclerosis—a report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 66:754–763
3.
Jacobsen S, Ullman S, Shen GQ, Wiik A, Haberq P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed
4.
Diot E, Giraudeau B, Diot P, Degenee D, Ritz L, Guilmot JL, Lemarie E (1999) Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 116:715–720PubMedCrossRef
5.
Steen VD (2005) Autoantibodies in systemic sclerosis. Seminars Arthritis Rheum 35:35–42CrossRef
6.
Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726PubMedCrossRef
7.
Hu PQ, Fertig N, Medsger TA Jr, Wright TM (2003) Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 48:1363–1373PubMedCrossRef
8.
Hénault J, Tremblay M, Clément I, Raymond Y, Senécal Y (2004) DNA binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 50:3265–3274PubMedCrossRef
9.
Hénault J, Robtaille G, Senécal Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I antibodies from systemic sclerosis patients. Arthritis Rheum 54:963–973PubMedCrossRef
Metadata
Title
Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report
Authors
Paola Caramaschi
Alessandro Volpe
Antonio Carletto
Lisa Maria Bambara
Domenico Biasi
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0434-2

Other articles of this Issue 4/2008

Rheumatology International 4/2008 Go to the issue

Reply to the letter

Reply to the article: Initiating etanercept in a once weekly dose in children with juvenile idiopathic arthritis by Femke H.M. Prince, Lisette W.A. van Suijlekom-Smit

Short Communication

Acute psycosis in systemic lupus erythematosus

Letter to the Editor

Initiating etanercept in a once weekly dose in children with juvenile idiopathic arthritis

Original Article

Pathogenesis-related adhesion molecules in Henoch–Schonlein vasculitis

Original Article

Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis

Original Article

Clinical features of Thai male lupus: an age-matched controlled study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits